Skip to content

Clinical trials

Completed Phase 2 Thyroid Cancer, Papillary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Phase: Phase 2 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20044
20052
20061
20072
20082
20101
20122
20131
20141
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Academic and Community Cancer Research United2
Amgen1
Bhavana Konda1
Kenneth Ain1
Massachusetts General Hospital1
Medstar Health Research Institute1
Ohio State University Comprehensive Cancer Center1
Ottawa Regional Cancer Centre1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary23
Thyroid Neoplasms21
Adenocarcinoma, Follicular20
Carcinoma, Medullary10
Head and Neck Neoplasms6
Thyroid Carcinoma, Anaplastic4
Carcinoma, Hepatocellular2
Liver Neoplasms2
Adrenocortical Carcinoma1
Astrocytoma1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.